The injectable drugs are in high demand, though, which has led to availability problems on the market
However, this can lead to side effects like nausea or constipation
However, although commonly reported by patients, these symptoms are mostly mild, are rarely a reason for discontinuation of therapy, and seem to decrease over time with ongoing treatment.7,25e27 Although gastrointestinal side-effects occurred commonly in the large cardiovascular outcome trials, most were reported in the first weeks after initiation and they only led to discontinuation of treatment in 1e3% of cases.10,11 On the ICU, GLP-1 was also found to decrease gastric motility, although its effect was minimal when gastric emptying was already delayed.28 In patients with diabetes mellitus, gastroparesis is a known complication that requires attention and appropriate action by anaesthesiologists
Utah clients notice appetite control and energy improvements early on
Our office is at 111 High Ridge Rd., Stamford, CT 06905 Read more our posts
Ipamorelin is notable for its selectivity: unlike older GHRPs (such as GHRP-6), it stimulates GH release without significantly raising cortisol, prolactin, or appetite